RenovoRx, Inc.
RNXTDrugs in Pipeline
11
Phase 3 Programs
3
Upcoming Catalysts
3
Next Catalyst
Jun 23, 2026
2dMarket Overview
Stock performance and key metrics
3 upcoming, 1 past
Conference
RenovoRx CEO Shaun Bagai is scheduled to present at the iAccess Alpha Virtual Best Ideas Summer Investment Conference 2026 on June 23rd.
Source2 more catalysts beyond 14 days
Start a 48-hour free trial to see all upcoming catalysts
Juvista (avotermin)
Cicatrix
Gemcitabine
Locally Advanced Pancreatic Cancer
estradiol (Zesteem)
Burn
Avotermin (Juvista)
Cicatrix
Intradermal avotermin
Cicatrix
Mannose-6-Phosphate (Juvidex)
Wound
Zesteem
Cicatrix
Avotermin (RN1001)
Cicatrix
Prevascar
Cicatrix
Juvidex
Cicatrix
Avotermin
Cicatrix
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Juvista (avotermin) | Phase 3 | Cicatrix | - | - |
Gemcitabine | Phase 3 | Locally Advanced Pancreatic Cancer | - | - |
estradiol (Zesteem) | Phase 3 | Burn | - | - |
Avotermin (Juvista) | Phase 2 | Cicatrix | - | - |
Intradermal avotermin | Phase 2 | Cicatrix | - | - |
Mannose-6-Phosphate (Juvidex) | Phase 2 | Wound | - | - |
Zesteem | Phase 2 | Cicatrix | - | - |
Avotermin (RN1001) | Phase 2 | Cicatrix | - | - |
Prevascar | Phase 2 | Cicatrix | - | - |
Juvidex | Phase 2 | Cicatrix | - | - |
Avotermin | Phase 2 | Cicatrix | - | - |